Kostenlos

CCSF Investment Talk: Biotech Innovation - Made in Switzerland

Eventinformationen

Dieses Event teilen

Datum und Uhrzeit

Veranstaltungsort

Veranstaltungsort

Zentrum Karl der Grosse

14 Kirchgasse

Grosser Saal

8001 Zürich

Switzerland

Karte anzeigen

Beschreibung des Events

Beschreibung

„Biotech Innovation - Made in Switzerland“

Switzerland, as a center of biotech excellence, offers global reach, risk-conscious funding and scientific brilliance! We explore this interaction with people who are in the middle of it:

Dr. Stefanie Flückiger-Mangual, CEO, Tolremo - One of Tolremo's scientific founders and expert in the field of drug resistance in cancer therapy. She led the team of scientists who discovered novel molecular mechanisms that can be exploited to prevent the development of resistance to cancer therapies.

Prof. Dr. Paul Herrling - he was one of the key scientific & business decision makers as Global Head of Research during his tenure at Novartis. He currently advises biotech venture funds and start-up companies.

Dr. Valentin Piëch, Investment Director at BioMedPartners, Basel - a Swiss Venture Capital Firm investing in private early- to mid-stage life science companies that address important medical needs with novel technologies or products that are backed by compelling science.

Moderator: Dr Myoung-Ok Kwon - Head of Healthcare Investment, PMG Investment Solutions, Zürich

Start of event at 10:00 (Doors open at 09:45). Afterwards Networking, Kaffee und Gipfli.

The Investment Talk is in English.

Mit Freunden teilen

Datum und Uhrzeit

Veranstaltungsort

Zentrum Karl der Grosse

14 Kirchgasse

Grosser Saal

8001 Zürich

Switzerland

Karte anzeigen

Dieses Event speichern

Event gespeichert